Bio equivalency tests for 199 drugs to be reviewed.

Published: 2006-09-14 06:57:00

Updated: 2006-09-14 06:57:00

The KFDA announced that about 130 drugs could be cancelled due to the bio equivalency test manipulation and other 199 drugs which were unable clearly to interpret the data (the items unable to recover its original data) should be reviewed or directed to conduct the comparative dissolution tests. ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK